Mirae Asset Global ETFs Holdings
LRMR icon

Mirae Asset Global ETFs Holdings’s Larimar Therapeutics LRMR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.5K Buy
30,652
+7,561
+33% +$30K ﹤0.01% 2856
2026
Q1 		$104K Buy
23,091
+544
+2% +$2.17K ﹤0.01% 2650
2025
Q4 		$85.9K Buy
22,547
+704
+3% +$2.74K ﹤0.01% 2737
2025
Q3 		$70.6K Sell
21,843
-2,274
-9% -$8.53K ﹤0.01% 2828
2025
Q2 		$69.7K Sell
24,117
-1,092
-4% -$2.53K ﹤0.01% 2775
2025
Q1 		$54.2K Buy
25,209
+1,092
+5% +$3.45K ﹤0.01% 2835
2024
Q4 		$93.3K Buy
24,117
+1,064
+5% +$7.02K ﹤0.01% 2732
2024
Q3 		$151K Buy
23,053
+10,037
+77% +$80.7K ﹤0.01% 2511
2024
Q2 		$94.4K Buy
+13,016
New +$99.7K ﹤0.01% 2587

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LRMR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Larimar Therapeutics (LRMR) stake by 33% in Q2 2026, buying an estimated $30K and bringing the position to 30,652 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Mirae Asset Global ETFs Holdings first reported a position in LRMR in Q2 2024 and has held it in 9 quarters since. The position peaked at $151K in Q3 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 30,652 shares of Larimar Therapeutics worth $93.5K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 7,561 Larimar Therapeutics shares in Q2 2026, an estimated $30K.
  • Larimar Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2856 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Larimar Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Larimar Therapeutics position peaked at $151K in Q3 2024.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.